Entity Common Stock, Shares Outstanding of Keenova Therapeutics plc from 31 Jul 2013 to 07 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Keenova Therapeutics plc quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2013 to 07 Nov 2025.
  • Keenova Therapeutics plc Entity Common Stock, Shares Outstanding for the quarter ending 07 Nov 2025 was 39,526,162, a 101% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Keenova Therapeutics plc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 39,526,162 +19,829,827 +101% 07 Nov 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 39,413,711 +19,717,376 +100% 05 Aug 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 19,762,306 +65,971 +0.34% 28 Feb 2025 10-K 13 Mar 2025 2024 FY
Q3 2024 19,696,335 +6,324,628 +47% 01 Nov 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 19,696,335 +6,407,155 +48% 02 Aug 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 19,696,335 +6,525,403 +50% 22 Mar 2024 10-K 26 Mar 2024 2023 FY
Q3 2023 13,371,707 +200,775 +1.5% 03 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 13,289,180 +118,248 +0.9% 09 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 13,170,932 -71,563,148 -84% 05 May 2023 10-Q 09 May 2023 2023 Q1
Q3 2022 13,170,932 -71,552,836 -84% 04 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 13,170,932 -71,544,946 -84% 10 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 84,734,080 +25,614 +0.03% 11 Mar 2022 10-K 15 Mar 2022 2021 FY
Q3 2021 84,723,768 +118,906 +0.14% 29 Oct 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 84,715,878 +126,911 +0.15% 30 Jul 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 84,708,466 +253,182 +0.3% 15 Apr 2021 10-K/A 19 Apr 2021 2020 FY
Q3 2020 84,604,862 +511,495 +0.61% 30 Oct 2020 10-Q 03 Nov 2020 2020 Q2
Q2 2020 84,588,967 +580,411 +0.69% 31 Jul 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 84,455,284 +641,464 +0.76% 01 May 2020 10-Q 06 May 2020 2020 Q1
Q3 2019 84,093,367 +780,127 +0.94% 01 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 84,008,556 +799,070 +0.96% 02 Aug 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 83,813,820 +729,002 +0.88% 03 May 2019 10-Q 07 May 2019 2019 Q1
Q3 2018 83,313,240 -11,691,672 -12% 02 Nov 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 83,209,486 -13,969,282 -14% 03 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 83,084,818 -16,261,766 -16% 04 May 2018 10-Q 08 May 2018 2018 Q1
Q3 2017 95,004,912 03 Nov 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 97,178,768 -10,534,552 -9.8% 04 Aug 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 99,346,584 -9,978,927 -9.1% 01 May 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 104,694,686 -7,220,180 -6.5% 03 Feb 2017 10-QT 07 Feb 2017 2016 Q4
Q2 2016 107,713,320 -9,629,214 -8.2% 29 Jul 2016 10-Q 02 Aug 2016 2016 Q3
Q1 2016 109,325,511 -7,649,445 -6.5% 29 Apr 2016 10-Q 03 May 2016 2016 Q2
Q4 2015 111,914,866 -4,567,490 -3.9% 29 Jan 2016 10-Q 02 Feb 2016 2016 Q1
Q2 2015 117,342,534 +58,768,625 +100% 27 Jul 2015 10-Q 04 Aug 2015 2015 Q3
Q1 2015 116,974,956 +58,497,786 +100% 27 Apr 2015 10-Q 05 May 2015 2015 Q2
Q4 2014 116,482,356 +58,479,984 +101% 30 Jan 2015 10-Q 03 Feb 2015 2015 Q1
Q3 2014 116,278,655 14 Nov 2014 8-K 03 Apr 2015 2014 FY
Q2 2014 58,573,909 +876,725 +1.5% 01 Aug 2014 10-Q 07 Aug 2014 2014 Q3
Q1 2014 58,477,170 02 May 2014 10-Q 08 May 2014 2014 Q2
Q4 2013 58,002,372 06 Dec 2013 10-K 13 Dec 2013 2013 FY
Q2 2013 57,697,184 31 Jul 2013 10-Q 12 Aug 2013 2013 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.